Karina Gasbarrino
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Karina Gasbarrino has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Stella Styliani Daskalopoulou
McGill University Health Centre
5 shared publications - Bénédicte Nauche
Medical Libraries, McGill University Health Centre, Montreal, QC, Canada
3 shared publications - Jessica Gorgui
Department of Medicine, Faculty of Medicine, McGill University, Montreal, Quebec, Canada
2 shared publications - Robert Côté
Department of Neurology and Neurosurgery, McGill University, Montreal, Quebec, Canada
2 shared publications - Adel Schwertani
Division of Cardiology, McGill University Health Centre, Montreal, Quebec, Canada
1 shared publication - Anouar Hafiane
Department of Medicine, Faculty of Medicine, Research Institute of the McGill University Health Centre, Montreal, Canada
1 shared publication
Latest Publications
- 1 November 2019
- Published by Elsevier in Metabolism
- Vol. 100, 153953
The role of adiponectin in cholesterol efflux and HDL biogenesis and metabolism
- 1 November 2019
- Published by Elsevier in Metabolism
- Vol. 100, 153953
The role of adiponectin in cholesterol efflux and HDL biogenesis and metabolism
- Open Access
- 5 December 2018
- Published by Springer Nature in Systematic Reviews
- Vol. 7 (1) , 225
Bioactive scaffolds in stem-cell-based therapies for cardiac repair: protocol for a meta-analysis of randomized controlled preclinical trials in animal myocardial infarction models
Acute myocardial infarction (MI) remains one of the leading causes of death worldwide with no curative therapy available. Stem cell therapies have been gaining interest as a means to repair the cardiac tissue after MI and prevent the onset of heart failure. Many in vivo reports suggest that the use of stem cells is promising, yet clinical trials suggest that the cells fail to integrate into the native tissue, resulting in limited improvements in cardiac function and repair. To battle this limitation, the combination of using stem cells embedded in a bioactive scaffold that promotes cell retention is growing in interest. Yet, a systematic review of the literature on the use of stem cells embedded in bioactive scaffolds for cardiac repair has not yet been performed. In this protocol, we outline a systematic review and meta-analysis of preclinical trials in animal MI models that utilize stem cell-embedded scaffolds for cardiac repair and compare their effects to stem cell-treated animals without the use of a scaffold. We will search the following electronic databases: Cochrane Library, MEDLINE, Embase, PubMed, Scopus and Web of Science, and gray literature: Canadian Agency for Drugs and Technologies in Health and Google Scholar. We will only include randomly controlled preclinical trials that have directly investigated the effects of stem cells embedded in a scaffold for cardiac repair in an animal MI model. Two investigators will independently review each article included in the final analysis. The primary endpoint that will be investigated is left ventricular ejection fraction. Secondary endpoints will include infarct size, end systolic volume, end diastolic volume, fractional shortening and left ventricular wall thickness. Pooled analyses will be conducted using the DerSimonian-Laird random effects and Mantel-Haenszel fixed-effect models. Between-studies heterogeneity will be quantified and determined using the Tau2 and I2 statistics. Publication bias will be assessed using visual inspection of funnel plots and complemented by Begg’s and Egger’s statistical tests. Possible sources of heterogeneity will be assessed using subgroup-meta analysis and meta-regression. To date, the use of scaffolds in myocardial repair has not yet been systematically reviewed. The results of this meta-analysis will aid in determining the efficacy of stem cell-embedded scaffolds for cardiac repair and help bring this therapy to the clinic.
- 5 December 2018
- Published by Springer Nature in Systematic Reviews
- Vol. 7 (1) , 225
Open AccessBioactive scaffolds in stem-cell-based therapies for cardiac repair: protocol for a meta-analysis of randomized controlled preclinical trials in animal myocardial infarction models
Acute myocardial infarction (MI) remains one of the leading causes of death worldwide with no curative therapy available. Stem cell therapies have been gaining interest as a means to repair the cardiac tissue after MI and prevent the onset of heart failure. Many in vivo reports suggest that the use of stem cells is promising, yet clinical trials suggest that the cells fail to integrate into the native tissue, resulting in limited improvements in cardiac function and repair. To battle this limitation, the combination of using stem cells embedded in a bioactive scaffold that promotes cell retention is growing in interest. Yet, a systematic review of the literature on the use of stem cells embedded in bioactive scaffolds for cardiac repair has not yet been performed. In this protocol, we outline a systematic review and meta-analysis of preclinical trials in animal MI models that utilize stem cell-embedded scaffolds for cardiac repair and compare their effects to stem cell-treated animals without the use of a scaffold. We will search the following electronic databases: Cochrane Library, MEDLINE, Embase, PubMed, Scopus and Web of Science, and gray literature: Canadian Agency for Drugs and Technologies in Health and Google Scholar. We will only include randomly controlled preclinical trials that have directly investigated the effects of stem cells embedded in a scaffold for cardiac repair in an animal MI model. Two investigators will independently review each article included in the final analysis. The primary endpoint that will be investigated is left ventricular ejection fraction. Secondary endpoints will include infarct size, end systolic volume, end diastolic volume, fractional shortening and left ventricular wall thickness. Pooled analyses will be conducted using the DerSimonian-Laird random effects and Mantel-Haenszel fixed-effect models. Between-studies heterogeneity will be quantified and determined using the Tau2 and I2 statistics. Publication bias will be assessed using visual inspection of funnel plots and complemented by Begg’s and Egger’s statistical tests. Possible sources of heterogeneity will be assessed using subgroup-meta analysis and meta-regression. To date, the use of scaffolds in myocardial repair has not yet been systematically reviewed. The results of this meta-analysis will aid in determining the efficacy of stem cell-embedded scaffolds for cardiac repair and help bring this therapy to the clinic.
- 1 September 2016
- Published by Elsevier in Metabolism
- Vol. 65 (9) , 1434-1442
Corrigendum to “circulating adiponectin and carotid intima-media thickness: a systematic review and meta-analysis” [Metabolism 65 (2016) 968–986]
- 1 September 2016
- Published by Elsevier in Metabolism
- Vol. 65 (9) , 1434-1442
Corrigendum to “circulating adiponectin and carotid intima-media thickness: a systematic review and meta-analysis” [Metabolism 65 (2016) 968–986]
- 1 July 2016
- Published by Elsevier in Metabolism
- Vol. 65 (7) , 968-986
Circulating adiponectin and carotid intima-media thickness: A systematic review and meta-analysis
- 1 July 2016
- Published by Elsevier in Metabolism
- Vol. 65 (7) , 968-986
Circulating adiponectin and carotid intima-media thickness: A systematic review and meta-analysis
- 1 June 2014
- Published by Elsevier in Hearing Research
- Vol. 312, 60-68
Mechanisms of radiation-induced sensorineural hearing loss and radioprotection
- 1 June 2014
- Published by Elsevier in Hearing Research
- Vol. 312, 60-68
Mechanisms of radiation-induced sensorineural hearing loss and radioprotection